Trials / Completed
CompletedNCT01076491
High Dose Inhaled Mannitol Study
A Pilot Study to Investigate the Feasibility and Tolerability of Inhaling a High Dose of Dry Powder Mannitol (IDPM) Per Breath Administered Via a Dry Powder Inhaler Loaded With a Single Capsule in Subjects With Bronchiectasis
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Syntara · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to investigate the safety and tolerability of high doses of inhaled mannitol in subjects with bronchiectasis to further direct development of an improved drug delivery system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mannitol | inhaled mannitol - single doses of either 70 mg or 90 mg |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2009-03-01
- Completion
- 2009-04-01
- First posted
- 2010-02-26
- Last updated
- 2010-02-26
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT01076491. Inclusion in this directory is not an endorsement.